Search results
2,065 Shares in GSK plc (NYSE:GSK) Acquired by Scarborough Advisors LLC
ETF DAILY NEWS· 17 hours agoScarborough Advisors LLC bought a new position in GSK plc (NYSE:GSK – Free Report) during the 4th quarter, according to its most recent Form 13F filing ...
The $3bn crisis casting a shadow over Dame Emma Walmsley’s GSK
Daily Telegraph· 13 hours agoThe British executive managed to ride out the storm by demerging GSK’s consumer brands into new company Haleon and focusing on pharmaceuticals. Since then ...
GSK Says Individual Plaintiff in Latest Zantac Case Dropped Claim
The Wall Street Journal· 6 days agoGSK said the trial was scheduled to start on Monday in Illinois, adding that it didn’t reach a...
GSK and Ochre Bio link to explore liver disease drivers
Pharmaceutical Technology via Yahoo Finance· 4 days agoIn June 2024 GSK acquired Elsie Biotechnologies for $50m to unlock the potential of oligonucleotide...
GSK plc (NYSE:GSK) Shares Bought by Neuberger Berman Group LLC
ETF DAILY NEWS· 6 days agoNeuberger Berman Group LLC grew its stake in shares of GSK plc (NYSE:GSK – Free Report) by 5.7% in the fourth quarter, according to the company in its most ...
Myriad Genetics (MYGN) and GSK Unite to Boost HRD Testing
Zacks via Yahoo Finance· 4 days agoGiven the market potential, the collaboration between Myriad Genetics and GSK is likely to benefit...
Moderna’s combo COVID and flu vaccine works better than stand-alone shots on the market, study finds
Market Watch· 7 days agoexperimental combination COVID and flu vaccine triggered better immune responses than stand-alone...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 4 days agoThe pharmaceutical company's EPS Rating, a measure of profitability, is 32 out of a best-possible...
Questor: Investors are undervaluing this London company’s pubs and hotels
The Telegraph via Yahoo Finance· 6 days agoWe are hopefully not tempting providence by taking a fresh look at Fuller Smith & Turner ahead of...
Corporate Nature Strategy Critical To Tackling $58 Trillion At Risk
Forbes· 5 days agoBiopharma giant GSK and luxury brand owner Kering are among five corporations that have had their...